Search

Your search keyword '"Slim, Marleen A."' showing total 33 results

Search Constraints

Start Over You searched for: Author "Slim, Marleen A." Remove constraint Author: "Slim, Marleen A."
33 results on '"Slim, Marleen A."'

Search Results

2. Towards personalized medicine: a scoping review of immunotherapy in sepsis

4. Lack of association between classical HLA genes and asymptomatic SARS-CoV-2 infection

5. Biomarker Analysis Provides Evidence for Host Response Homogeneity in Patients With COVID-19

6. 25-Hydroxyvitamin D concentrations do not affect the humoral or cellular immune response following SARS-CoV-2 mRNA vaccinations

7. The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees

8. Platelets of COVID-19 patients display mitochondrial dysfunction, oxidative stress, and energy metabolism failure compatible with cell death

9. Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines

10. Anti-C5a antibody (vilobelimab) therapy for critically ill, invasively mechanically ventilated patients with COVID-19 (PANAMO): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

11. Inflammatory subphenotypes previously identified in ARDS are associated with mortality at intensive care unit discharge: a secondary analysis of a prospective observational study

12. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

13. 25-Hydroxyvitamin D concentrations do not affect the humoral or cellular immune response following SARS-CoV-2 mRNA vaccinations

14. Comparative analysis of spike-specific IgG Fc glycoprofiles elicited by adenoviral, mRNA, and protein-based SARS-CoV-2 vaccines

15. Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study

16. The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylated IgG1 in naive but not in antigen-experienced vaccinees

18. ImmunoSep (Personalised Immunotherapy in Sepsis) international double-blind, double-dummy, placebo-controlled randomised clinical trial: study protocol

19. Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

20. Inflammatory biomarkers at hospital discharge are associated with readmission and death in patients hospitalized for COVID-19

21. Anti-C5a antibody vilobelimab treatment and the effect on biomarkers of inflammation and coagulation in patients with severe COVID-19: a substudy of the phase 2 PANAMO trial

22. Time since SARS-CoV-2 infection and humoral immune response following BNT162b2 mRNA vaccination

23. Personalised immunotherapy in sepsis: a scoping review protocol

24. The risk of COVID-19 death is much greater and age-dependent with type I IFN autoantibodies

25. Neurofilament light increases over time in severe COVID-19 and is associated with delirium

26. The BNT162b2 mRNA SARS-CoV-2 Vaccine Induces Transient Afucosylated IgG1 in Naive But Not in Antigen-Experienced Vaccinees

27. Real-world Evidence of the Effects of Novel Treatments for COVID-19 on Mortality: A Nationwide Comparative Cohort Study of Hospitalized Patients in the First, Second, Third, and Fourth Waves in the Netherlands.

28. Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deaths

29. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19

30. Clinical features and prognostic factors in Covid-19: A prospective cohort study

31. Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [123I]FP-CIT SPECT imaging by neurologists in patients with early drug-naive Parkinson's disease.

32. Clinical Subtype Trajectories in Sepsis Patients Admitted to the ICU: A Secondary Analysis of an Observational Study.

33. Age-related changes in plasma biomarkers and their association with mortality in COVID-19.

Catalog

Books, media, physical & digital resources